Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bisbenthiamine is a lipid-soluble disulfide derivative of thiamine (Vitamin B1) that functions as a prodrug with enhanced bioavailability compared to standard thiamine salts. By crossing cell membranes more effectively, it provides a sustained supply of thiamine, which is subsequently phosphorylated into thiamine pyrophosphate (TPP). TPP is a critical cofactor for several key enzymes in carbohydrate metabolism, including pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, and transketolase. Bisbenthiamine is utilized to treat Vitamin B1 deficiency and associated conditions such as beriberi, Wernicke-Korsakoff syndrome, and various forms of peripheral neuropathy. Skanttr Lifescience includes this small molecule in its nutritional product portfolio as an approved therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bisbenthiamine.